Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/04/2012 | US20120252726 Novel neurotrophic factors |
10/04/2012 | US20120252717 Conjugates of biologically active proteins having a modified in vivo half-life |
10/04/2012 | US20120252099 Immunogenic minicells and methods of use |
10/04/2012 | US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins |
10/04/2012 | US20120252069 Process for the purification of glycoproteins |
10/04/2012 | US20120252068 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
10/04/2012 | US20120252067 Systems for the Expression of Orthogonal Translation Components in Eubacterial Host Cells |
10/04/2012 | US20120252066 Methods of foam control |
10/04/2012 | US20120252065 Aqueous process for preparing protein isolate and hydrolyzed protein from an oilseed |
10/04/2012 | US20120252064 Protease Enzyme and Uses Thereof |
10/04/2012 | US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
10/04/2012 | US20120251579 Compositions for generating an antigen specific immune response |
10/04/2012 | US20120251554 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses |
10/04/2012 | US20120251541 Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation |
10/04/2012 | US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
10/04/2012 | US20120251446 Peptide Conjugates Comprising Polyhistidine Sequence and Free Cysteine and Their Uses in Imaging |
10/04/2012 | CA2831770A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity |
10/04/2012 | CA2830338A1 Antibody-drug conjugates |
10/03/2012 | EP2505058A1 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies |
10/03/2012 | EP2504360A1 Monomeric antibody fc |
10/03/2012 | EP2504355A1 Method for making polypeptides |
10/03/2012 | CN1993463B Follistatin mutant polypeptide |
10/03/2012 | CN1846000B HPV CD8+ T-cell epitopes |
10/03/2012 | CN102712945A Methods and compositions for the treatment of proliferative and pathogenic diseases |
10/03/2012 | CN102712923A Anti-iga1 antibody |
10/03/2012 | CN102712921A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof |
10/03/2012 | CN102712696A Coiled coil and/or tether containing protein complexes and uses thereof |
10/03/2012 | CN102712694A Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene |
10/03/2012 | CN102711811A Antibody mimetic scaffolds |
10/03/2012 | CN102711810A Antibody Fc mutants with ablated effector functions |
10/03/2012 | CN102711809A Combination therapy of cancer with anti-endoglin antibodies and anti-VEGF agents |
10/03/2012 | CN102711795A BChE albumin fusions for the treatment of cocaine abuse |
10/03/2012 | CN102703555A Extraction and preparation method for micromolecule fishskin collagen peptide |
10/03/2012 | CN102703554A Method for preparing oyster polypeptide from oyster shell |
10/03/2012 | CN102703553A Method for using polysaccharide stem grafting coupling technique to improving pig plasma protein peptide antioxidant activity |
10/03/2012 | CN102703552A Preparation method and products of recombinant human insulin |
10/03/2012 | CN102703551A Novel method for adding decanoic acid in fermentation process of daptomycin |
10/03/2012 | CN102703550A Method for extracting protein from high density fermentation broth of bacillus cereus |
10/03/2012 | CN102703470A Compositions and methods for modulating pigment production in plants |
10/03/2012 | CN102703468A Gene and polypeptide for regulating and controlling plant height of crop and application of polypeptide |
10/03/2012 | CN102703457A Method for preparing and expressing antibacterial peptide gene |
10/03/2012 | CN102703446A Compositions of trna and uses thereof |
10/03/2012 | CN102703393A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
10/03/2012 | CN102702727A Preparation method for antibacterial composite material |
10/03/2012 | CN102701507A Method for treating high-concentration wastewater of glutamic acid |
10/03/2012 | CN102060922B Recombined human estrogen Alpha receptor ligand binding domain protein as well as preparation and application thereof |
10/03/2012 | CN102021193B Method for producing polypeptide by combining biological expression of protein with chemical cracking technique |
10/03/2012 | CN101568647B Secretion of antibodies without signal peptides from bacteria |
10/03/2012 | CN101180313B Fermentation process for the production of diphtheria toxin |
10/02/2012 | US8278498 Method for producing immortalised antibodies-secreting cells |
10/02/2012 | US8278427 Molecule for assigning genotype to phenotype and components thereof as well as method for constructing assigning molecule and method for utilizing assigning molecule |
10/02/2012 | US8278424 Antibodies that bind to PSCA proteins for diagnosis of cancer |
10/02/2012 | US8278423 Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) |
10/02/2012 | US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof |
10/02/2012 | US8278421 Human antibodies specific for gastrin materials and methods |
10/02/2012 | US8278270 HGF precursor protein variant and active protein thereof |
10/02/2012 | US8278269 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine |
10/02/2012 | US8278085 RNA processing protein complexes and uses thereof |
10/02/2012 | US8278068 Ex vivo human skin model |
10/02/2012 | US8278065 Polynucleotides encoding anti-GD2 antibodies |
10/02/2012 | US8278045 Methods for the detection, analysis and isolation of nascent proteins |
10/02/2012 | US8278042 Compositions and methods for the diagnosis and treatment of tumor |
10/02/2012 | US8278037 N-acetylgalactosamine transferases and nucleic acids encoding the same |
10/02/2012 | US8277820 Process for preparing variant of Erysipelothrix rhusiopathiae surface protective antigen in E. coli |
10/02/2012 | US8277804 Antagonists of IL-6 to prevent or treat thrombosis |
10/02/2012 | US8277803 Cancerous disease modifying antibodies |
10/02/2012 | CA2711007C G-csf analog compositions and methods |
10/02/2012 | CA2492883C Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
10/02/2012 | CA2467215C Emulsion compositions |
10/02/2012 | CA2430135C Recombinant anti-cd30 antibodies and uses thereof |
10/02/2012 | CA2396534C Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
10/02/2012 | CA2345356C Transformation system in the field of filamentous fungal hosts |
10/02/2012 | CA2223269C Hepatocyte growth factor receptor antagonists and uses thereof |
10/02/2012 | CA2133306C Amplification of human mdm2 gene in human tumors |
09/27/2012 | WO2012129342A1 Compositions and methods for enhancing the pluripotency of stem cells |
09/27/2012 | WO2012129036A2 Promoters for high level recombinant expression in fungal host cells |
09/27/2012 | WO2012128661A1 Fusion protein, fusion protein-producing strain of escherichia coli bacteria and a method for producing methionine-free human interferon alpha-2b from said fusion protein |
09/27/2012 | WO2012128143A1 Monoclonal antibody specific to west nile viral structural protein and method for determining west nile viral infection using monoclonal antibody |
09/27/2012 | WO2012128082A1 Anti-mouse aggrus monoclonal antibody |
09/27/2012 | WO2012126134A2 Recombinant cell that has a mutated cellular iron-transport mechanism and is transformed with a sequence that codes for a sulphur permease and with a sequence that codes for a high-affinity phosphate transporter, suitable for extracting phosphorus and/or sulphur from a solid or liquid medium that may have a high iron content |
09/27/2012 | US20120245327 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated |
09/27/2012 | US20120245103 Silk Proteins |
09/27/2012 | US20120244636 Incorporation of methyl lysine into polypeptides |
09/27/2012 | US20120244578 Monomeric antibody fc |
09/27/2012 | US20120244577 Multivalent heteromultimer scaffold design and constructs |
09/27/2012 | US20120244576 Compositions and methods for improved protein production |
09/27/2012 | US20120244575 Cyclotide genes in the fabaceae plant family |
09/27/2012 | US20120244176 Protein having immunogenicity of cedar pollen, polynucleotide encoding the protein, and use thereof |
09/27/2012 | US20120244175 Tumor specific animal proteins |
09/27/2012 | US20120244164 Biological materials related to c-met |
09/27/2012 | US20120244163 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
09/27/2012 | US20120244162 Cross-species-specific bispecific binders |
09/27/2012 | US20120244159 Specific Antibodies To Amyloid Beta Peptide, Pharmaceutical Compositions And Methods Of Use Thereof |
09/27/2012 | US20120244154 Activatable Binding Polypeptides and Methods of Identification and Use Thereof |
09/27/2012 | US20120244152 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof |
09/27/2012 | US20120244148 Anti-interferon-alpha antibodies |
09/27/2012 | US20120244112 Mutant interleukin-2 polypeptides |
09/27/2012 | US20120244076 csPCNA Isoform Antibodies And Uses Thereof |
09/27/2012 | CA2836007A1 Mouse anti-aggrus monoclonal antibodies |
09/26/2012 | EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile |